Literature DB >> 30114697

ANTXR1 Intronic Variants Are Associated with Fetal Hemoglobin in the Arab-Indian Haplotype of Sickle Cell Disease.

Zhara A Al-Ali1, Rana K Fallatah1, Esra A Aljaffer1, Eman R Albukhari1, Neriman Sadek Al-Ali1, Ziyad T Al-Ghannam1, Reem Sayeb Al-Atrash1, Ahmed Alsuliman2, Chittibabu Vatte3.   

Abstract

Disease severity of sickle cell anemia is highly variable, and it is commonly accepted that fetal hemoglobin (HbF) levels play a major role as an ameliorating factor. Investigation of genetic variants have identified several genes to be the principal influencers of HbF regulation. Here, we further elucidated the association of rs4527238 and rs35685045 of ANTXR1 genes in the context of HbF level variance in sickle cell anemia patients of the Arab-Indian haplotype. Samples from 630 sickle cell anemia patients were analyzed for the mutations at 2 specific locations of the ANTXR1 gene by TaqMan®-based real-time PCR. The CC genotype (p = 0.018) of rs4527238 and the TT genotype (p = 0.048) of rs35685045 of ANTXR1 were found to be significantly associated with low HbF expression. The frequency of the CC genotype of rs4527238 was observed to be high in the low HbF patient group compared to the high HbF group (p = 0.009). Likewise, the frequency of the TT genotype of rs35685045 was also high among the low HbF group (p = 0.017). The ANTXR1 genetic mutations and the association with HbF expression in the Arab-Indian haplotype sickle cell patients revealed that the ANTXR1 gene may be a major HbF modulator leading to potential therapeutic options that should be further explored.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Fetal hemoglobin; Genetic polymorphism; Haplotype; Sickle cell anemia

Mesh:

Substances:

Year:  2018        PMID: 30114697     DOI: 10.1159/000491688

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  5 in total

Review 1.  Fetal hemoglobin in sickle cell anemia.

Authors:  Martin H Steinberg
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

2.  Sickle cell disease in the era of precision medicine: looking to the future.

Authors:  Martin H Steinberg; Sara Kumar; George J Murphy; Kim Vanuytsel
Journal:  Expert Rev Precis Med Drug Dev       Date:  2019-11-07

3.  Protocol for "Genetic composition of sickle cell disease in the Arab population: A systematic review".

Authors:  Fateen Ata; Zohaib Yousaf; Sundus Sardar; Saad Javed; Phool Iqbal; Ibraheem Khamees; Lujain Salahaldeen Malkawi; Mohamed A Yassin
Journal:  Health Sci Rep       Date:  2022-05-03

4.  Transmembrane Protein ANTXR1 Regulates γ-Globin Expression by Targeting the Wnt/β-Catenin Signaling Pathway.

Authors:  Tingting Jin; Zhaojun Zhang; Yuanyuan Han; Di Li; Juan Liu; Minmin Jiang; Junwei Zhu; Ryo Kurita; Yukio Nakamura; Fangfang Hu; Yongjie Xu; Xiangdong Fang; Shengwen Huang; Zhaolin Sun
Journal:  J Immunol Res       Date:  2022-07-30       Impact factor: 4.493

5.  ANTXR1 Regulates Erythroid Cell Proliferation and Differentiation through wnt/β-Catenin Signaling Pathway In Vitro and in Hematopoietic Stem Cell.

Authors:  Tingting Jin; Zhaojun Zhang; Yuanyuan Han; Di Li; Juan Liu; Minmin Jiang; Ryo Kurita; Yukio Nakamura; Fangfang Hu; Xiangdong Fang; Shengwen Huang; Zhaolin Sun
Journal:  Dis Markers       Date:  2022-08-27       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.